Elixir Medical has announced that it will stream the first live transmission case demonstration of its Desolve Cx novolimus-eluting bioresorbable coronary scaffold system at TCT (11–15 October, San Francisco, USA). The live case will be presented on Monday 12 October and the Elixir satellite symposium is scheduled for Wednesday 14 October.
An Elixir Medical press release reports the following schedule for Elixir’s activities at the conference:
12 October—8.45am: Moscone South, Esplanade Level, Main Arena
Desolve Cx Live Case
12 October—3.26—3.33pm: Moscone West, 3rd Floor, Room 3001–05
Device and clinical program highlights: DESyne BD
14 October—1-2pm: Moscone South, Lower Level, Exhibit Hall, Presentation Theater 3
Elixir Satellite Symposium: Transforming PCI with the DESolve Novolimus Eluting Scaffold Platforms
Chairs: Alexandre Abizaid (Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil), Martin B Leon (New York – Presbyterian Hospital / Columbia University Medical Center, New York, USA)
Faculty: (Ian MeredithMonash Medical Centre, Melbourne, Australia), Holger Nef (head of the Cardiac Catheterization Laboratory, University Hospital Giessen, Giessen, Germany), John Ormiston, (Mercy Angiographic Unit, Auckland, New Zealand). Space is limited: Please register in advance here
14 October—7.17—7.24pm: Ballroom Level, Continental Ballroom 1-4
Thin struts with self-correcting property (DESolve)
Elixir Medical will have a booth at TCT: Booth 1533, Exhibit Hall. The booth will be open Monday, October 12 through Wednesday, October 14 from 9am—5pm.
